Market Condition: Flat Open. Market Bounce

Commentary: Reasonable bounce yesterday in the market. No real catalysts showing up today so not much to do in terms of new catalysts. Remains to be seen as to whether yesterday was short term relief or part of a broader bounce.

Plenty of stocks still in decent shape for earnings if they can tighten up over the next week or two. No rush here. The opportunities will come along and the plan is to hit them hard. Don’t get caught up here in FOMO or looking over the fence at people trading different styles.

Options Expiry today which will likely produce whipsaw action.

This is a good time to clear the victims from your watchlists and find the stocks that are still building strong charts.

PR Catalyst · Magnitude · Mkt cap $8.4B · Float 222M · SI 6.3% (2.4 days) · NYSE · Theme: Enterprise Software > Marketing Software · Next earnings 3 Nov

Why: ZETA Launches DARPA Collaboration to Advance Robotic, Neuronavigated Single-Day TMS.

This is a rehashed headline but there are three strong upgrades today. Chart at All time high. Has potential to Breakout having shown strong RS to the market. Possibly better watch for earnings Nov 10th

Level: 35 U&R

MRNA - Power Play - 17th September 2026 - 49% Remaining

OKTA - Earnings Catalyst - 15th October 2026 - 20EMA Close Below

TQQQ - Other - 15th October 2026 - Closed Intraday

Friday October 16 2026 (monthly options expiry)

8:30 AM - Export Prices MoM (Sep) (Previous: 1.2%, Consensus: 1%)

8:30 AM - Import Prices MoM (Sep) (Previous: 0.5%, Consensus: 0.8%)

9:15 AM - Industrial Production MoM (Sep) (Previous: 0%, Consensus: 0.4%)

2:00 PM - Budget Balance (Sep) (Previous: -167 B, Consensus: -29 B)

3:30 PM - CFTC Gold Speculative net positions (Previous: 210.3 K, Consensus: —)

3:30 PM - CFTC S&P 500 speculative net positions (Previous: -154.1 K, Consensus: —)

3:30 PM - CFTC Nasdaq 100 speculative net positions (Previous: 58.1 K, Consensus: —)

3:30 PM - CFTC Crude Oil speculative net positions (Previous: 99.1 K, Consensus: —)

4:00 PM - Net Long-Term TIC Flows (Aug) (Previous: -27.9 B, Consensus: 75.2 B)

Fed speakers: Goolsbee 6:00 PM

Fri 16 Oct: CTY - City Therapeutics, Inc. Common Stock - NASDAQ - We are a clinical-stage biotechnology company developing the next generation of RNA interference (“RNAi”) therapeutics designed to silence the expression of disease-relevant proteins, with the aim of delivering meaningful and durable benefits for patients in need.

XBI +0.3% on the week and -2.9% on the month, under its 50-day. The sector tailwind is gone for now. Reactions have to prove themselves.

Flagged Charts: None

Note: Never front-run biotech catalysts. Wait for the catalyst to hit, then assess if the reaction is tradable. Dates are estimates and can shift.

Full H2 Biotech Watchlist: TradingView

Have a Great Weekend!

Sean Sharpe